Patents Assigned to Gesea Biosciences Inc.
-
Patent number: 11833244Abstract: A drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a pharmacologically active agent over an extended time period. As such, the drug delivery system finds significant utility in chronic drug administration. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods for manufacturing and using the drug delivery system are also provided.Type: GrantFiled: November 19, 2021Date of Patent: December 5, 2023Assignee: Gesea Biosciences Inc.Inventors: John H. Baillie, Ruth Baillie, George Blouin, Newsha Farahani, Christopher Marx
-
Publication number: 20220249365Abstract: A drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a pharmacologically active agent over an extended time period. As such, the drug delivery system finds significant utility in chronic drug administration. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods for manufacturing and using the drug delivery system are also provided.Type: ApplicationFiled: November 19, 2021Publication date: August 11, 2022Applicant: Gesea Biosciences Inc.Inventors: John H. Baillie, Ruth Baillie, George Blouin, Newsha Farahani, Christopher Marx
-
Patent number: 11185496Abstract: A drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a pharmacologically active agent over an extended time period. As such, the drug delivery system finds significant utility in chronic drug administration. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods for manufacturing and using the drug delivery system are also provided.Type: GrantFiled: January 28, 2019Date of Patent: November 30, 2021Assignee: GESEA BIOSCIENCES, INC.Inventors: John H. Baillie, Ruth Baillie, George Blouin, Newsha Farahani, Christopher Marx
-
Patent number: 10406099Abstract: A contraceptive drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a contraceptive agent over an extended time period. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods of using the drug delivery system, including in female contraception, are also provided.Type: GrantFiled: April 24, 2018Date of Patent: September 10, 2019Assignee: GESEA BIOSCIENCES, INC.Inventors: John H. Baillie, Ruth Baillie, George Blouin, Newsha Farahani, Christopher Marx
-
Publication number: 20190151235Abstract: A drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a pharmacologically active agent over an extended time period. As such, the drug delivery system finds significant utility in chronic drug administration. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods for manufacturing and using the drug delivery system are also provided.Type: ApplicationFiled: January 28, 2019Publication date: May 23, 2019Applicant: Gesea Biosciences Inc.Inventors: John H. BAILLIE, Ruth BAILLIE, George BLOUIN, Newsha FARAHANI, Christopher MARX
-
Patent number: 10188602Abstract: A drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a pharmacologically active agent over an extended time period. As such, the drug delivery system finds significant utility in chronic drug administration. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods for manufacturing and using the drug delivery system are also provided.Type: GrantFiled: September 29, 2017Date of Patent: January 29, 2019Assignee: GESEA BIOSCIENCES INC.Inventors: John H. Baillie, Ruth Baillie, George Blouin, Newsha Farahani, Christopher Marx
-
Publication number: 20180303659Abstract: A contraceptive drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a contraceptive agent over an extended time period. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods of using the drug delivery system, including in female contraception, are also provided.Type: ApplicationFiled: April 24, 2018Publication date: October 25, 2018Applicant: Gesea Biosciences Inc.Inventors: John H. BAILLIE, Ruth BAILLIE, George BLOUIN, Newsha FARAHANI, Christopher MARX
-
Patent number: 9980850Abstract: A contraceptive drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a contraceptive agent over an extended time period. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods of using the drug delivery system, including in female contraception, are also provided.Type: GrantFiled: September 29, 2017Date of Patent: May 29, 2018Assignee: GESEA BIOSCIENCES, INC.Inventors: John H. Baillie, Ruth Baillie, George Blouin, Newsha Farahani, Christopher Marx
-
Publication number: 20180085248Abstract: A contraceptive drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a contraceptive agent over an extended time period. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods of using the drug delivery system, including in female contraception, are also provided.Type: ApplicationFiled: September 29, 2017Publication date: March 29, 2018Applicant: Gesea Biosciences Inc.Inventors: John H. BAILLIE, Ruth BAILLIE, George BLOUIN, Newsha FARAHANI, Christopher MARX
-
Publication number: 20180085305Abstract: A drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a pharmacologically active agent over an extended time period. As such, the drug delivery system finds significant utility in chronic drug administration. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods for manufacturing and using the drug delivery system are also provided.Type: ApplicationFiled: September 29, 2017Publication date: March 29, 2018Applicant: Gesea Biosciences Inc.Inventors: John H. BAILLIE, Ruth BAILLIE, George BLOUIN, Newsha FARAHANI, Christopher MARX